News & Perspective

Feb 01, 2019

Feb 01, 2019

ASP Scan (Weekly) for Feb 01, 2019

Animal stewardship partnership
Antibiotic pipeline details
New PACCARB members
Decline in UK antibiotics
Superbug bloodstream infections in Greece
Antibiotics and malaria prevention
Promising antifungal candidate
Proposed UN AMR guidance
Proposed UN AMR guidance
Antibiotic use in nursing homes
Novel antibiotic vs C diff
Pharmacist interventions
Antibiotics for asthma attack

May 10, 2018

May 10, 2018

News Scan for May 10, 2018

Canadian romaine E coli cases
Burkholderia cepacia outbreak
Yellow fever in Brazil
Avian flu outbreaks
Polio emergency continues

Nov 17, 2017

Nov 17, 2017

ASP Scan (Weekly) for Nov 17, 2017

Primary care stewardship
No-touch superbug disinfection
Surgical antimicrobial prescribing
Ceftriaxone-resistant gonorrhea
E coli ST131
Single-room ICU design
ECDC CRE guidance
European research funding
Optimal MDR-TB treatment
Real-time resistance tracker
Salmonella in calves
Drug-resistant malaria controversy
US AMR progress
Antimicrobial use in Northern Ireland
Resistance in space

Feb 24, 2017

Feb 24, 2017

News Scan for Feb 24, 2017

Zika vaccine targets
Yellow fever in Brazil
Canada beef irradiation
Candidate E coli vaccine

Jan 09, 2015

Jan 09, 2015

News Scan for Jan 09, 2015

Meningococcal vaccine for infants
Dengue vaccine
2 Saudi MERS cases
H5N2 outbreak in Taiwan
Listeria-linked apple recall

May 18, 2011

May 18, 2011

Experts: Regulatory issues are main reason for keeping smallpox virus

(CIDRAP News) – When the World Health Assembly (WHA) considers the fate of the remaining stocks of smallpox virus this week, the debate is likely to be framed in part by a report from a group of independent experts that says the only strong reason for keeping the virus is to satisfy strict regulatory requirements for new vaccines and antivirals.

Pages

by country

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»